CRA acquires bioStrategies Group, Inc.
Today CRA announced its acquisition of bioStrategies Group, Inc., a Chicago-based consulting firm focused on developing commercial strategies for healthcare...
Mike Kaestle is Vice President in the Life Sciences Practice at CRA. He has led more than 170 studies in the past five years. Mike has extensive experience in forecasting, new product planning, and commercial evaluations, and due diligence projects in support of investment decisions. He works with numerous private equity companies, as well as business development leads at manufacturing companies to value life science assets. Mike also serves as an expert witness in life science product valuation litigation.
Prior to joining CRA, Mike was the Co-Founder, Partner, and President of bioStrategies Group, a firm offering research and analysis in support of commercial strategy decisions to life science companies. He also worked in private equity at Crabtree Capital and in microeconomic analysis in support of litigation at National Economic Research Associates (NERA).